Skip to main content

HEALTHPEAK PROP. Inc. Value Stock - Dividend - Research Selection

Hcp

ISIN: US42250P1030 , WKN: A2N5NP

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index. For more information regarding HCP, visit www.hcpi.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor Access

2026-09-01
Healthpeak Properties, Inc. (NYSE: DOC): A Leading Healthcare-Focused REITSAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery. The company owns a national portfolio composed of 700 properties totaling nearly 50 million square feet. Advisor Access spoke with Scott Brinker,

Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24

2026-08-31
Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.

DOC vs. EGP: Which Stock Is the Better Value Option?

2026-08-28
DOC vs. EGP: Which Stock Is the Better Value Option?

Institutions Are Buying Real Estate Blind

2026-08-20
Q2 2026 13F filings show institutions added shares across 95% of 158 US real estate stocks for over $300M. Read more on the real estate stocks here.

Healthpeak Properties Inc's Dividend Analysis

2026-08-17
This article first appeared on GuruFocus. Healthpeak Properties Inc (NYSE:DOC) recently announced a total dividend of $0.1 per share, with the ex-dividend date set for 2026-09-14. This includes a $0.1 per share cash dividend payable on 2026-09-25.

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

2026-08-17
In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.

Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

2026-08-13
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.

Healthpeak Properties (DOC) Q2 2026 Earnings Call Transcript

2026-08-11
Occupancy gains in lab and outpatient medical segments drive raised full-year guidance.

Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

2026-08-11
Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.

Is the Options Market Predicting a Spike in Healthpeak Properties Stock?

2026-08-10
Investors need to pay close attention to DOC stock based on the movements in the options market lately.